We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
With competition in the U.S. generics market mashing down margins, some drugmakers have been selling or closing plants to cut costs. India's Sun Pharma has joined that trend and will close a plant in New Jersey, costing nearly 100 workers their jobs.